Cargando…

Increased Circulating MicroRNA-155 as a Potential Biomarker for Breast Cancer Screening: A Meta-Analysis

The objective of this meta-analysis was to determine the diagnostic accuracy of circulating microRNA-155 (miR-155) for breast cancer (BC). PubMed, Embase, EBSCO (ASP/BSP), Cochrane Library and China National Knowledge Infrastructure (CNKI) were searched up to 30 January 2014 for eligible studies. Qu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Faliang, Hou, Jinchao, Jin, Wei, Li, Jiaqiu, Yue, Yongfang, Jin, Hongchuan, Wang, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270988/ https://www.ncbi.nlm.nih.gov/pubmed/24840899 http://dx.doi.org/10.3390/molecules19056282

Ejemplares similares

Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers
por: Li, Jiaqiu, et al.
Publicado: (2014)

MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges
por: Lan, Huiyin, et al.
Publicado: (2015)

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection
por: Ma, Yanning, et al.
Publicado: (2013)

Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma
por: ElKashef, Sabrin Mohamed Mohamed Abd Elhamed, et al.
Publicado: (2020)

Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis
por: Hou, Yi, et al.
Publicado: (2016)

Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics
por: Knoka, Evija, et al.
Publicado: (2020)

Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression
por: Niu, Lian-Jie, et al.
Publicado: (2021)

Diagnostic performance of circulating MicroRNAs in acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Cao, Wenzhai, et al.
Publicado: (2020)

A meta-analysis of the relationship between circulating microRNA-155 and coronary artery disease
por: Ran, Tao, et al.
Publicado: (2023)

MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications
por: Sun, Jie, et al.
Publicado: (2013)

Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Serum MicroRNA-155 as a Potential Biomarker to Track Disease in Breast Cancer
por: Sun, Yu, et al.
Publicado: (2012)

Role of MicroRNA-155 as a Potential Biomarker for Allergic Rhinitis in Children
por: Hammad, Noha M., et al.
Publicado: (2021)

MicroRNA-155: Regulation of Immune Cells in Sepsis
por: Chen, Ming, et al.
Publicado: (2021)

In Silico Screening of Circulating MicroRNAs as Potential Biomarkers for the Diagnosis of Ovarian Cancer
por: Wu, Lei, et al.
Publicado: (2019)

The multiple roles of microRNA-155 in oncogenesis
por: Higgs, Gadareth, et al.
Publicado: (2013)

MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)

MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
por: Gao, Yuewen, et al.
Publicado: (2018)

Circulating MicroRNAs as Biomarkers for Sepsis
por: Benz, Fabian, et al.
Publicado: (2016)

MicroRNA-155 from sputum as noninvasive biomarker for diagnosis of active pulmonary tuberculosis
por: Ying, Hua, et al.
Publicado: (2020)

Circulating MicroRNAs as Biomarkers of Acute Stroke
por: Sepramaniam, Sugunavathi, et al.
Publicado: (2014)

Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer
por: Liu, Xuemin, et al.
Publicado: (2021)

Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection
por: Bala, Shashi, et al.
Publicado: (2012)

MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone
por: Kara, Sonat Pınar, et al.
Publicado: (2021)

MicroRNA-155 and Its Role in Malignant Hematopoiesis
por: Ranganath, Prajnya
Publicado: (2015)

The Emerging Role of MicroRNA-155 in Cardiovascular Diseases
por: Cao, Richard Y., et al.
Publicado: (2016)

The MicroRNA miR-155 Is Essential in Fibrosis
por: Eissa, Mousa G., et al.
Publicado: (2019)

Increased microRNA-155 and decreased microRNA-146a may promote ocular inflammation and proliferation in Graves’ ophthalmopathy
por: Li, Kaijun, et al.
Publicado: (2014)

Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
por: Wang, Jun, et al.
Publicado: (2015)

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Circulating microRNAs as biomarkers in bile-derived exosomes of cholangiocarcinoma
por: Han, Jin-Yi, et al.
Publicado: (2021)

Circulating MicroRNAs: Potential Biomarkers for Cancer
por: Yu, De-Cai, et al.
Publicado: (2011)

Circulating microRNAs as biomarkers - True Blood?
por: Schöler, Nathalie, et al.
Publicado: (2011)

MicroRNA‐155 (miR-155) as an accurate biomarker of periodontal status and coronary heart disease severity: a case–control study
por: Daily, Zina A., et al.
Publicado: (2023)

Circulating microRNAs as potential diagnostic biomarkers for osteoporosis
por: Mandourah, Abdullah Y., et al.
Publicado: (2018)

Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage
por: Wang, Hao, et al.
Publicado: (2018)

Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer
por: Yan, Shushan, et al.
Publicado: (2017)

The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis
por: Zeng, Hui, et al.
Publicado: (2014)

Circulating MicroRNAs as Diagnostic Biomarkers for Motor Neuron Disease
por: Wang, Lin, et al.
Publicado: (2020)

Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
por: Ng, Enders K. O., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ffdbtsjrmjhdpb1q2389ilctq